Orbital mantle cell lymphoma

被引:0
作者
El Maaroufi, H. [1 ]
Chahdi, K. El Ouazzani [2 ]
Doghmi, K. [1 ]
Mikdame, M. [1 ]
机构
[1] Univ Mohamed V Souissi, Hop Mil Instruct Mohammed V, Serv Hematol Clin, Rabat 10100, Morocco
[2] Univ Mohamed V Souissi, Hop Specialites, Serv Ophtalmol A, Rabat 10112, Morocco
来源
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2013年 / 36卷 / 04期
关键词
Mantle cell lymphoma; Orbital lymphoma; Proptosis; RITUXIMAB; SURVIVAL;
D O I
10.1016/j.jfo.2012.06.024
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Ophthalmological involvement in mantle cell lymphoma is rare. An 84-year-old man presented with bilateral proptosis. Orbital biopsy established the diagnosis of mantle cell lymphoma. The diagnosis of mantle cell lymphoma is anatomopathological and immunohistochemical. Orbital involvement is found most often in advanced stages of the disease, but may be the presenting sign as in the case of our patient. Treatment has improved with the use of rituximab, especially in elderly patients not eligible for autologous hematopoietic stem cell transplant. (C) 2013 Published by Elsevier Masson SAS.
引用
收藏
页码:E55 / E57
页数:3
相关论文
共 50 条
  • [31] Mantle cell lymphoma: a Turkish Multi-Center Study
    Okay, Mufide
    Meletli, Ozgur
    Kelkitli, Engin
    Malkan, Umit Yavuz
    Turgut, Mehmet
    Buyukasik, Yahya
    Tekin, Fatma
    Demiroglu, Haluk
    Goker, Hakan
    JOURNAL OF BUON, 2019, 24 (05): : 2084 - 2089
  • [32] Mantle cell lymphoma
    Le Gouill, Steven
    Dousset, Christelle
    Gastinne, Thomas
    Brousseau, Carole
    Peterlin, Pierre
    Touzeau, Cyrille
    Pellat-Deceunynck, Catherine
    Amiot, Martine
    Moreau, Anne
    HEMATOLOGIE, 2011, 17 (05): : 322 - 330
  • [33] Mantle cell lymphoma
    John J. Densmore
    Michael E. Williams
    Current Treatment Options in Oncology, 2003, 4 (4) : 281 - 287
  • [34] Maintenance Therapy in Diffuse Large B Cell Lymphoma and Mantle Cell Lymphoma
    Till, Brian G.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (09)
  • [35] Maintenance Therapy in Diffuse Large B Cell Lymphoma and Mantle Cell Lymphoma
    Brian G. Till
    Current Treatment Options in Oncology, 2018, 19
  • [36] Can the prognosis of mantle cell lymphoma be predicted by simple CBC counts?
    Sahin, Hannan Haydarogiu
    MEDICINE, 2019, 98 (30) : e16180
  • [37] Mantle cell lymphoma epidemiology: a population-based study in France
    Leux, Christophe
    Maynadie, Marc
    Troussard, Xavier
    Cabrera, Quentin
    Herry, Aurelie
    Le Guyader-Peyrou, Sandra
    Le Gouill, Steven
    Monnereau, Alain
    ANNALS OF HEMATOLOGY, 2014, 93 (08) : 1327 - 1333
  • [38] Current and Emerging Therapies in Mantle Cell Lymphoma
    Brett, L. Kyle
    Williams, Michael E.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2013, 14 (02) : 198 - 211
  • [39] Activity of Thalidomide and Lenalidomide in Mantle Cell Lymphoma
    Richardson, S. J.
    Eve, H. E.
    Copplestone, J. A.
    Dyer, M. J.
    Rule, S. A. J.
    ACTA HAEMATOLOGICA, 2010, 123 (01) : 21 - 29
  • [40] Radiotherapy in mantle cell lymphoma: A literature review
    Ben Barouch, Sharon
    Kurvilla, John
    Tsang, Richard W.
    Yashphe, Eva
    Sarid, Nadav
    HEMATOLOGICAL ONCOLOGY, 2020, 38 (03) : 223 - 228